BCR and B-cell chronic lymphocytic leukemia: Remarkably, the proliferative subnetwork identified by modeling the response of aggressive CLL lymphocytes to BCR activation with costimulating agents comprised several genes encoding important TFs downstream the BCR signaling pathway, including genes previously identified in common in the lymphocytic response to BCR alone in healthy donors and patients with indolent or aggressive CLL [15] (Table S2).